- Home
- PHAR vs SBET Comparison
PHAR vs SBET Comparison
Compare PHAR & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- SBET
- Stock Information
- Founded
- PHAR 1988
- SBET 1995
- Country
- PHAR Netherlands
- SBET United States
- Employees
- PHAR N/A
- SBET N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- PHAR Health Care
- SBET Technology
- Exchange
- PHAR Nasdaq
- SBET Nasdaq
- Market Cap
- PHAR 707.9M
- SBET 618.0M
- IPO Year
- PHAR N/A
- SBET 1997
- Fundamental
- Price
- PHAR $10.96
- SBET $17.14
- Analyst Decision
- PHAR Strong Buy
- SBET
- Analyst Count
- PHAR 3
- SBET 0
- Target Price
- PHAR $30.00
- SBET N/A
- AVG Volume (30 Days)
- PHAR 5.3K
- SBET 55.8M
- Earning Date
- PHAR 07-31-2025
- SBET 08-14-2025
- Dividend Yield
- PHAR N/A
- SBET N/A
- EPS Growth
- PHAR N/A
- SBET N/A
- EPS
- PHAR N/A
- SBET N/A
- Revenue
- PHAR $339,836,000.00
- SBET $3,428,134.00
- Revenue This Year
- PHAR $12.88
- SBET N/A
- Revenue Next Year
- PHAR $8.54
- SBET N/A
- P/E Ratio
- PHAR N/A
- SBET N/A
- Revenue Growth
- PHAR 22.44
- SBET N/A
- 52 Week Low
- PHAR $6.73
- SBET $2.26
- 52 Week High
- PHAR $12.61
- SBET $124.12
- Technical
- Relative Strength Index (RSI)
- PHAR 58.06
- SBET 43.68
- Support Level
- PHAR $9.54
- SBET $18.37
- Resistance Level
- PHAR $10.46
- SBET $28.50
- Average True Range (ATR)
- PHAR 0.37
- SBET 4.91
- MACD
- PHAR 0.10
- SBET -1.06
- Stochastic Oscillator
- PHAR 81.20
- SBET 0.21
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.